Application of serum protein fingerprint in diagnosis of coronary artery disease

Clinical Biochemistry

Volumn 44, Issue 2-3, 2011, Pages 185-191

  Wang, Yaping ^a   Hu, Xinyang ^a   Wang, Jian An ^a   Xiang, Meixiang ^a   Yu, Jiekai ^a   Liu, Fangfei ^a   Feng, Yan ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Coronary artery disease; Diagnosis; Protein profile; Surface enhanced laser desorption ionization

Indexed keywords

ADULT; AGED; ARTICLE; BIOCHIP; BIOINFORMATICS; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; EARLY DIAGNOSIS; FEMALE; HUMAN; MALE; MOLECULAR DIAGNOSIS; MOLECULAR MODEL; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MASS SPECTROMETRY; PEPTIDE MAPPING; PROTEIN MICROARRAY;

PLASMA PROTEIN;

BLOOD PROTEINS; CORONARY ARTERY DISEASE; HUMANS; PEPTIDE MAPPING; PROTEIN ARRAY ANALYSIS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 79151469549     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2010.10.003     Document Type: Article

References (30)

1. Gaziano J.M. Global burden of cardiovascular disease. Heart disease: a textbook of cardiovascular medicine 2001, 1-18. W.B. Saunders Company, Philadelphia. 6th ed. E. Braunwald, D.P. Zipes, P. Libby (Eds.).
2. Cheng T.O. Price of modernization of China. Circulation 2001, 103:e132.
3. Cieniewski-Bernard C., Acosta A., Dubois E., et al. Proteomic analysis in cardiovascular diseases. Clin Exp Pharmacol Physiol 2008, 35:362-366.
4. Edwards A.V., White M.Y., Cordwell S.J. The role of proteomics in clinical cardiovascular biomarker discovery. Mol Cell Proteomics 2008, 7:1824-1837.
5. Issaq H.J., Conrads T.P., Prieto D.A., Tirumalai R., Veenstra T.D. SELDI-TOF MS for diagnostic proteomics. Anal Chem 2003, 75:148A-155A.
6. Ward D.G., Nyangoma S., Joy H., et al. Proteomic profiling of urine for the detection of colon cancer. Proteome Sci 2008, 6:19.
7. Zhang X., Jin M., Wu H., et al. Biomarkers of lupus nephritis determined by serial urine proteomics. Kidney Int 2008, 74:799-807.
8. Wilson A.M., Kimura E., Harada R.K., et al. Beta2-microglobulin as a biomarker in peripheral arterial disease: proteomic profiling and clinical studies. Circulation 2007, 116:1396-1403.
9. Sun B., Rempel H.C., Pulliam L. Loss of macrophage-secreted lysozyme in HIV-1-associated dementia detected by SELDI-TOF mass spectrometry. AIDS 2004, 29:1009-1012.
10. Yuditskaya S., Tumblin A., Hoehn G.T., et al. Proteomic identification of altered apolipoprotein patterns in pulmonary hypertension and vasculopathy of sickle cell disease. Blood 2009, 113:1122-1128.
11. Arrell D.K., Neverova I., Van Eyk J.E. Cardiovascular proteomics: evolution and potential. Circ Res 2001, 88:763-773.
12. Issaq H.J., Veenstra T.D., Conrads T.P., Felschow D. The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification. Biochem Biophys Res Commun 2002, 292:587-592.
13. Bashore T.M., Bates E.B., Berger P.B., et al. Task Force on Clinical Expert Consensus Documents: American College of Cardiology/Society for Cardiac Angiography and Interventions Clinical Expert Consensus Document on cardiac catheterization laboratory standards. A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2001, 37:2170-2214.
14. Smith S.C., Feldman T.E., Hirshfeld J.W., et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines; ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention: ACC/AHA/SCAI 2005 Guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (ACC/AHA/SCAI writing committee to update the 2001 guidelines for percutaneous coronary intervention). J Am Coll Cardiol 2006, 47:e1-e121.
15. Wang J.X., Yu J.K., Wang L., Liu Q.L., Zhang J., Zheng S. Application of serum protein fingerprint in diagnosis of papillary thyroid carcinoma. Proteomics 2006, 6:5344-5349.
16. Jaffe A.S. Cardiovascular biomarkers: the state of the art in 2006. Clin Chim Acta 2007, 381:9-13.
17. Jaffe A.S., Babuin L., Apple F.S. Biomarkers in acute cardiac disease: the present and the future. J Am Coll Cardiol 2006, 48:1-11.
18. Bart B.A., Shaw L.K., McCants C.B., et al. Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J Am Coll Cardiol 1997, 30:1002-1008.
19. Henneman M.M., Schuijf J.D., van der Wall E.E., Bax J.J. Non-invasive anatomical and functional imaging for the detection of coronary artery disease. Br Med Bull 2006, 79-80:187-202.
20. Rispler S., Keidar Z., Ghersin E., et al. Integrated single-photon emission computed tomography and computed tomography coronary angiography for the assessment of hemodynamically significant coronary artery lesions. J Am Coll Cardiol 2007, 49:1059-1067.
21. McCarthy R.M., Deshpande V.S., Beohar N., et al. Three-dimensional breathhold magnetization-prepared TrueFISP: a pilot study for magnetic resonance imaging of the coronary artery disease. Invest Radiol 2007, 42:665-670.
22. Slomka P.J., Le Meunier L., Hayes S.W., et al. Comparison of myocardial perfusion 82Rb PET performed with CT- and transmission CT-based attenuation correction. J Nucl Med 2008, 49:1992-1998.
23. Anagnostopoulos C., Almonacid A., El Fakhri G., et al. Quantitative relationship between coronary vasodilator reserve assessed by 82Rb PET imaging and coronary artery stenosis severity. Eur J Nucl Med Mol Imaging 2008, 35:1593-1601.
24. Di Carli M.F., Hachamovitch R. New technology for noninvasive evaluation of coronary artery disease. Circulation 2007, 115:1464-1480.
25. Morin R.L., Gerber T.C., McCollough C.H. Radiation dose in computed tomography of the heart. Circulation 2003, 107:917-922.
26. Shiwa M., Nishimura Y., Wakatabe R., et al. Rapid discovery and identification of a tissue-specific tumor biomarker from 39 human cancer cell lines using the SELDI ProteinChip platform. Biochem Biophys Res Commun 2003, 309:18-25.
27. Florian-Kujawski M., Hussain W., Chyna B., et al. Biomarker profiling of plasma from acute coronary syndrome patients: application of ProteinChip array analysis. Int Angiol 2004, 23:246-254.
28. Sato A., Aonuma K., Imanaka-Yoshida T., et al. Serum tenascin-C might be a novel predictor of left ventricular remodeling and prognosis after acute myocardial infarction. J Am Coll Cardiol 2006, 47:2319-2325.
29. Somorjai R.L., Dolenko B., Baumgartner R. Class prediction and discovery using gene microarray and proteomics mass spectroscopy data: curses, caveats, cautions. Bioinformatics 2003, 19:1484-1491.
30. Byvatov E., Schneider G. Support vector machine applications in bioinformatics. Appl Bioinform 2003, 2:67-77.